2nd Quarter - Report

TAYLOR STRATEGIES for PTC THERAPEUTICS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Seeking drug approval through the FDA.

LobbyistCovered position, as disclosed
LESLIE KRAMERICH —
BETTILOU TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.